Crewe Advisors’s Sotera Health SHC Stock Holding History

Crewe Advisors’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-86	Closed	-$1.54K	–	988
2023 Q1	$1.54K	Hold	86	–	–	﹤0.01%	736
2022 Q4	$716	Hold	86	–	–	﹤0.01%	950
2022 Q3	$1K	Hold	86	–	–	﹤0.01%	1192
2022 Q2	$2K	Buy	+86	New	+$1.8K	﹤0.01%	1007

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Crewe Advisors's SHC Position: Q2 2023 in Review

Crewe Advisors sold out of Sotera Health (SHC) in Q2 2023, closing a stake of 86 shares — an estimated $1.54K sold.

Crewe Advisors first reported a position in SHC in Q2 2022 and held it in 4 quarters. The position peaked at $2K in Q2 2022. 177 funds tracked by Wall St. Rank hold SHC as of Q2 2023.

Crewe Advisors reported no remaining Sotera Health position as of Q2 2023 after selling out during the quarter.
Crewe Advisors sold 86 Sotera Health shares in Q2 2023, an estimated $1.54K.
Crewe Advisors first reported a position in Sotera Health in Q2 2022 and held it in 4 quarters.
Crewe Advisors's Sotera Health position peaked at $2K in Q2 2022.
177 funds tracked by Wall St. Rank held Sotera Health as of Q2 2023.

Based on Crewe Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.